This review aims to dissect the contribution of the cells mentioned above and molecules (tau, βA, and TREM-2) of the innate immune compartment to the pathogenesis and progression of AD and their potential as disease biomarkers, and the design of tools toward these targets. The gene discussed is MAPT; the disease is Alzheimer disease.